Vitality Watch

Dossier pubmed observational 14-nov-2026
Human cohort, case-control, or epidemiological association

Association between Brain Amyloid Status and Cognitive and Physical Performance in Older Adults with Frailty Criteria: Longitudinal Data from the CogFrail Study.

Key claim: In cognitively impaired prefrail and frail older adults, brain amyloid pathology predicts faster cognitive decline over two years but is not associated with accelerated physical performance decline or loss of independence.

Abstract

BACKGROUND: The impact of cerebral amyloid pathology on cognitive and functional decline may differ with age. Evidence linking brain amyloidopathy to physical decline remains limited and inconsistent. This study investigated the association between brain amyloid status and cognitive and physical decline in (pre)frail older adults with cognitive impairment. METHODS: This longitudinal analysis used data from the CogFrail study. Brain amyloid pathology was assessed using amyloid-positron emission tomography (visual reading). Linear mixed-effects models examined differences over a two-year follow-up between amyloid-positive and amyloid-negative participants in cognitive, functional, and physical trajectories. Cognitive and functional outcomes included the Mini-Mental State Examination, the Clinical Dementia Rating-Sum of Boxes, the Activities of Daily Living Index, and a neuropsychological battery, while the physical domain was assessed using handgrip strength, chair rise time, gait speed, and the Short Physical Performance Battery. RESULTS: Among 199 participants (mean age 82.3 ± 4.8 years; 65.3% women), 108(54.3%) were amyloid-positive. Amyloid-positive participants experienced greater decline in the Clinical Dementia Rating-Sum of Boxes (β = 0.30, 95% CI 0.10-0.49; p = 0.003, log-transformed) and the Mini-Mental State Examination (β = -1.62, 95% CI -2.74 to -0.49; p = 0.005). No significant longitudinal differences were observed between groups in the Activities of Daily Living Index, neuropsychological outcomes, or physical performance measures. CONCLUSION: Amyloid pathology assessment may help differentiate cognitive trajectories in cognitively impaired (pre)frail older adults. Greater cognitive decline in amyloid-positive participants was not associated with greater loss of independence or additional physical decline over time. TRIAL REGISTRATION: NCT03129269.

Why this matters

[human-observational] CogFrail adds longitudinal evidence that brain amyloid status has different prognostic associations across aging domains: amyloid positivity was associated with faster cognitive decline, but not accelerated physical-performance decline or loss of independence over two years in cognitively impaired prefrail and frail older adults. [human-observational] These findings do not establish amyloid status as a general marker of functional aging or show that changing amyloid levels would change these outcomes.

Source

Link

Briefing card

Association between Brain Amyloid Status and Cognitive and Physical Performance in Older Adults with Frailty Criteria: Longitudinal Data from the CogFrail Study.
Stage: observational · pubmed · 14-nov-2026

If you are an older adult with cognitive impairment and prefrailty or frailty, this study linked amyloid positivity to faster cognitive decline, but not faster physical decline or loss of independence over two years.

In cognitively impaired prefrail and frail older adults, brain amyloid pathology predicts faster cognitive decline over two years but is not associated with accelerated physical performance decline or loss of independence.

Cross-references (0)

None recorded — doctrine links and citations appear here as scans and citation sweeps find them.

External: doi:10.1093/gerona/glag259

build build 880 · 2bcef25 · 2026-11-18